AXA IM ETFs

Greater choice, more possibilities

Why ETFs?

Exchange traded funds (ETFs) have seen enormous growth in the past 20 years due to a popular combination of:
  • The same all-in-one diversification offered by mutual funds
  • With the ease of trading like stocks
  • Full visibility of the underlying holdings

Traditionally passive investments, today’s ETFs have evolved to offer investors access to a much wider range of investment strategies, including an increasing number of actively managed funds.

Why AXA IM for ETFs?

We are committed to meeting the long-term needs of our investors and are at the forefront of the transformations shaping the future of investing. Our new ETF platform gives investors greater access to the AXA IM expertise they trust, in the format of their choice.

Combining expertise

Our ETF platform brings together:

  • The extensive investment experience of our multi-disciplined portfolio management teams.

  • ETF expertise through our dedicated in-house Capital Markets and Structured Asset Management teams

Accessing future-focused solutions

We believe the challenges and opportunities facing investors – and the world – demand solutions designed with the future in mind.

We have an established history of product innovation that does just that, with solutions that allow investors to benefit from themes ranging from climate change to the consumer digital revolution.

Benefitting from an ETF format

  • Easy access: readily traded on stock exchanges
  • Liquidity: priced in real time and can be bought and sold throughout the day
  • Transparency: portfolio holdings disclosed every day

Our capabilities

Our ETF offering will build on AXA IM’s long-standing strengths investing in areas including:
  • Sustainable equities
  • Credit
  • Technology

AXA IM ETFs offer easy access to our recognised expertise as well as the opportunity to further enhance our investment offering as economies, markets and client needs evolve.

Risk Warning

No assurance can be given that our investment strategies will be successful. Investors can lose some or all of their capital invested. Our strategies are subject to risks including, but not limited to: equity; emerging markets; global investments; investments in small and micro capitalisation universe; investments in specific sectors or asset classes specific risks, liquidity risk, credit risk, counterparty risk, legal risk, valuation risk, operational risk and risks related to the underlying assets.

    Disclaimer

    The classification of the [Fund] under SFDR may be subject to adjustments and amendments, since SFDR has come into force recently only and certain aspects of SFDR may be subject to new and/or different interpretations than those existing at the date of this [Prospectus/PPM]. As part of the ongoing assessment and current process of classifying its financial products under SFDR, [the Manager] reserves the right, in accordance with and within the limits of applicable regulations and of the [Fund]’s [legal documentation], to amend the classification of the Fund from time to time to reflect changes in market practice, its own interpretations, SFDR-related laws or regulations or currently-applicable delegated regulations, communications from national or European authorities or court decisions clarifying SFDR interpretations. Investors are reminded that they should not base their investment decisions on the information presented under SFDR only.

    This promotional communication does not constitute on the part of AXA Investment Managers a solicitation or investment, legal or tax advice. This material does not contain sufficient information to support an investment decision.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient.